Viewing Study NCT05391750


Ignite Creation Date: 2025-12-24 @ 5:25 PM
Ignite Modification Date: 2025-12-30 @ 4:51 AM
Study NCT ID: NCT05391750
Status: RECRUITING
Last Update Posted: 2025-01-24
First Post: 2022-04-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Venetoclax and Tocilizumab for the Treatment of Patients With Relapsed or Refractory t(11;14) Multiple Myeloma
Sponsor: Emory University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module